PEGGY DEPALMA: Open Payments
NPI 1790420511 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 8 payments from 6 companies in 2025. Trend: 2023 $92 · 2024 $199 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| Vantive US Healthcare LLC | 1 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| OPKO Pharmaceuticals, LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $8 |
Products named: Renal - PD, Kerendia, GIVLAARI, RAYALDEE, FARXIGA.
Industry payments across FL — which companies pay providers there.
